Systemic vitamin D3 attenuated oxidative injuries in the locus coeruleus of rat brain

Annals of the New York Academy of Sciences

Volumn 993, Issue , 2003, Pages 313-324

  Chen, Kuen Bor ^a   Lin, Anya Maan Yuh ^b   Chiu, Tsai Hsien ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Hippocampus; Iron; Locus coeruleus; Neuroprotection; Oxidative injuries; Vitamin D3

Indexed keywords

CALCITRIOL; CHLORAL HYDRATE; COLECALCIFEROL; CYTOCHROME C; IRON; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; BRAIN INJURY; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOSOL; DRUG EFFECT; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; LIVER LEVEL; LOCUS CERULEUS; MALE; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NICK END LABELING; NONHUMAN; NORADRENERGIC SYSTEM; OXIDATIVE STRESS; RAT;

ANIMALIA;

EID: 0038389440     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb07539.x     Document Type: Conference Paper

References (39)

1. AMMARAL, D.G. & H.M. SINNAMON. 1977. The locus coeruleus: neurobiology of central noradrenergic nucleus. Prog. Neurobiol. 9: 147-196.
2. LINDVALL, O., A. BJORKLUND, A. NOBIN & U. STENEVI. 1974. The adrenergic innervation of the rat thalamus as revealed by the glyoxylic acid fluorescence method. J. Comp. Neurol. 154: 317-348.
3. LINDVALL, O. & A. BJORKLUND. 1974. The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method. Acta Physiol. Scand. [Suppl.] 412: 1-48.
4. FOOTE, S.L., F.E. BLOOM & G. ASTON-JONES. 1983. Nucleus locus coeruleus: new evidence of anatomical and physiological specificity. Physiol. Rev. 63: 844-914.
5. LOUGHLIN, S.E., S.L. FOOTE & F.E. BLOOM. 1986. Efferent projections of nucleus locus coeruleus: topographic organization of cells of origin demonstrated by three-dimensional reconstruction. Neuroscience 18: 291-306.
6. LOUGHLIN, S.E., S.L. FOOTE & R. GRAZANNA. 1986. Efferent projections of nucleus locus coeruleus: morphologic subpopulations have different efferent targets. Neuroscience 18: 307-319.
7. SIEGEL, J.M. & M.A.A. ROGAWSKI. 1988. A function for REM sleep: regulation of noradrenergic receptor sensitivity. Brain Res. 472: 213-233.
8. CHU, N.S. & F.E. BLOOM. 1973. Norepinephrine-containing neurons changes in spontaneous discharge patterns during sleeping and waking. Science 179: 908-910.
9. JONES, S.L. & G.F. GEBHART. 1986. Characterization of coeruleospinal inhibition of the nociceptive tail-flick reflex in the rat: mediation by spinal alpha2-adrenoceptors. Brain Res. 364: 315-330.
10. PERLMAN, R. & G. GUIDERI. 1984. Cardiovascular changes produced by the injection of aconitine at the area of locus coeruleus in unanesthetized rats. Arch. Int. Pharmacodyn. 268: 202-215.
11. CHEN, J.Y., S.F. JANG & S.H.H. CHEN. 1992. Inhibition by locus coeruleus on the baroreceptor reflex response in the rat. Neurosci. Lett. 144: 225-228.
12. HERTZ, L. 1989. Is Alzheimer's disease an anterograde degeneration, origination in the brain stem, and disrupting metabolic and functional interactions between neurons and glial cells? Brain Res. Rev. 14: 335-353.
13. BUSCH, C., J. BOHL & T.G. OHM. 1997. Spatial, temporal and numeric analysis of Alzheimer changes in the locus coeruleus. Neurobiol. Aging 18: 401-406.
14. GESI, M., P. SOLDANI, F.S. GIORGI, et al. 2000. The role of the locus coeruleus in the development of Parkinson's disease. Neurosci. Biobehav. Rev. 24: 655-668.
15. DEXTER, D.T., F.R. WELLS, A.J. LEES, et al. 1994. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 52: 1830-1836.
16. SOFIC, E., W. PAULUS, K. JELLINGER, et al. 1991. Selective increase of iron in substantia nigra zona compacta of Parkinsonian brains. J. Neurochem. 56: 978-982.
17. CHRISTEN, Y. 2000. Oxidative stress and Alzheimer's disease. Am. J. Clin. Nutr. 71: 621S-629S.
18. WEISS, J.H., S.L. SENSI & J.Y. KOH. 2000. Zn(2+): a novel ionic mediator of neural injury in brain disease. Trends Pharmacol. Sci. 21: 395-401.
19. HALLIWELL, B. & J.M.C. GUTTERIDGE. 1999. The chemistry of free radicals and related "reactive species". In Free Radicals in Biology and Medicine. B. Halliwell & J.M.C. Gutteridge, Eds.: 36-104. Oxford University Press, New York.
20. COHEN, G. & P. WERNER. 1994. Free radicals, oxidative stress, and neurodegeneration. In Neurodegenerative Diseases. D.B. Calne, Ed.: 139-162. W.B. Saunders, Philadelphia.
21. JENNER, P. & C. W. OLANOW. 1996. Oxidative stress and pathogenesis of Parkinson's disease. Neurology 47: 161-170.
22. FLOYD, R.A. & J.M. CARNEY. 1992. Free radicals damage to protein and DNA: mechanisms involved and relevant observation on brain undergoing oxidative stress. Ann. Neurol. 32: S22-S27.
23. MECOCCI, P., U. MACGARVEY, A.E. KAUFMAN, et al. 1993. Oxidative damage to mitochondrial DNA shows marked age-dependent increase in human brain. Ann. Neurol. 34: 609-616.
24. BEN-SHACHAR, D. & M.B.H. YOUDIM. 1991. Intranigral iron injection induces behavioral and biochemical "Parkinsonism" in rats. J. Neurochem. 57: 2133-2135.
25. SENGSTOCK, G.J., C.W. OLANOW, A.J. DUNN, et al. 1994. Progressive changes in striatal dopaminergic markers, nigral volume, and rotational behavior following iron infusion into the rat substantial nigra. J. Neurol. 130: 82-94.
26. RAUHALA, P., K. PARAMESWARANNAY, I. SZIRAKI, et al. 1996. S-Nitrosothiols and nitric oxide, but not sodium nitroprusside protect nigrostriatal dopamine neurons against iron-induced oxidative stress in vivo. Synapse 23: 58-60.
27. RAUHALA, P., A.M.Y. LIN & C.C. CHIUEH. 1998. Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress. FASEB J. 12: 165-173.
28. LIN, A.M.Y. & L.T. HO. 2000. Melatonin suppresses iron-induced neurodegeneration in rat brain. Free Rad. Biol. Med. 28: 904-911.
29. YANG, Y.R., E.H.Y. LEE & T.H. CHIU. 1998. Electrophysiological and behavioral effects of Tyr-D-Arg-Phe-Sar on locus coeruleus neurons of the rat. Eur. J. Pharmacol. 351: 23-30.
30. KIKUGAWA, K., T. KATO, M. BEPPU, et al. 1989. Fluorescent and crosslinked protein formed by free radical and aldehyde species generated during lipid peroxidation. Adv. Exp. Med. Biol. 266: 345-356.
31. MOKANAKUMAR, K.P., A. DEBARTOLOMEIS, R.M. WU, et al. 1994. Ferrous citrate complex and nigral degeneration: evidence for free radical formation and lipid peroxidation. Ann. N.Y. Acad. Sci. 738: 392-399.
32. CHIUEH, C.C., Z. ZUKOWAKA-GROJEC, K.L. KIRK, et al. 1983. Fluorocatecholamines as false adrenergic neurotransmitters. J. Pharmacol. Exp. Ther. 225: 529-533.
33. 2+ injection. J. Neurochem. 42: 976-980.
34. ANLEZARK, G.M., T.J. CROW & A.P. GREENWAY. 1973. Impaired learning and decreased cortical norepinephrine after bilateral locus coeruleus lesions. Science 181: 682-684.
35. HARRO, J., A. MERIKULA, M. LEPIKU, et al. 2000. Lesioning of locus coeruleus projections by DSP-4 neurotoxin treatment: effect on amphetamine-induced hyperlocomotion and dopamine D2 receptor binding in rats. Pharmacol. Toxicol. 86: 197-202.
36. VELEZ-PARDO, C., D.R.M. JIMENEZ, H. VERSCHUEREN, et al. 1997. Dopamine and iron induce apoptosis in PC12 cells. Pharmacol. Toxicol. 80: 76-84.
37. WANG, J.Y., J.-N. WU, T.-L. CHERNG, et al. 2001. Vitamin D3 attenuates 6-hydroxydopamine-induced neurotoxicity in rat. Brain Res. 904: 67-75.
38. WANG, Y., Y.-H. CHIANG, T.-P. SU, et al. 2000. Vitamin D3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology 39: 873-880.
39. CHAO, C.C. & E.H.Y. LEE. 1999. Neuroprotective mechanism of glial cell line derived neurotrophic factor on dopamine neurons: role of antioxidation. Neuropharmacology 38: 913-916.